Listed by the USPTO as SCHULTZHAUS, JANNA NICOLE
Tech Center 1700 • Art Units: 1631 1671 1682 1685 1796
This examiner grants 35% of resolved cases
SCHULTZHAUS, JANNA NICOLE works in Tech Center 1700 and Art Unit 1631. Across 96 resolved cases, the allowance rate is 35.4%, the interview lift is 38.2%, and the median time to allowance is 1733 days. The record combines a relatively low allowance level with a strong interview measure and the longest reported median in this profile set.
The principal companies are Illumina Inc., Sony Group Corporation, and Micron Technology Inc. The leading firms are Dorsey & Whitney LLP-IP Dept.-MTI, MARSHALL, GERSTEIN & BORUN LLP, and Arch & Lake LLP. Practitioners may want to address prosecution risk early through focused claim drafting and well-prepared interviews.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17876493 | Designing Chemical or Genetic Perturbations using Artificial Intelligence | Non-Final OA | REGENTS OF THE UNIVERSITY OF MICHIGAN |
| 18428160 | INFORMATION PROCESSING SYSTEM, INFORMATION PROCESSING METHOD, NON-TRANSITORY COMPUTER-READABLE STORAGE MEDIUM AND SORTING SYSTEM | Final Rejection | Sony Group Corporation |
| 17915391 | METHOD AND APPARATUS FOR PREDICTING RNA-PROTEIN INTERACTION, MEDIUM AND ELECTRONIC DEVICE | Final Rejection | BOE TECHNOLOGY GROUP CO., LTD. |
| 17793968 | METHODS OF FUNCTIONALLY SCREENING BIOLOGICAL SEQUENCE FRAGMENTS | Final Rejection | Massachusetts Institute of Technology |
| 18136072 | QUANTIFYING THE RESPONSE-SPECIFICITY OF MONONUCLEAR CELLS AND USES THEREOF | Non-Final OA | The Regents of the University of California |
| 17328167 | METHODS FOR IDENTIFYING INTERACTIONS AMONGST MICROORGANISMS | Final Rejection | The Regents of the University of California |
| 18549621 | WORKFLOW TO ASSIGN PUTATIVE SOURCE TO DE NOVO PEPTIDE SEQUENCE | Non-Final OA | REGENERON PHARMACEUTICALS, INC. |
| 18021413 | CANCER TEST METHOD USING METABOLITE LIST | Non-Final OA | HITACHI HIGH-TECH CORPORATION |
| 17779959 | APPARATUS AND METHOD FOR DYNAMIC VISUALIZING AND ANALYZING MICROBIOME IN ANIMALS | Final Rejection | DSM IP Assets B.V. |
| 17599656 | PREDICTING CELL CULTURE PERFORMANCE IN BIOREACTORS | Final Rejection | AMGEN INC. |
| 16139699 | IMMUNE RECEPTOR-BARCODE ERROR CORRECTION | Final Rejection | Becton, Dickinson and Company |
| 17356146 | IN VIVO DETECTION OF EGFR MUTATION IN GLIOBLASTOMA VIA MRI SIGNATURE CONSISTENT WITH DEEP PERITUMORAL INFILTRATION | Non-Final OA | The Trustees of the University of Pennsylvania |
| 15758168 | MULTIPLE DATASET ANALYSIS FOR DETERMINING THE PRESENCE OR ABSENCE OF TARGET ANALYTE | Final Rejection | SEEGENE, INC. |
| 18359502 | RAPID SINGLE-CELL MULTIOMICS PROCESSING USING AN EXECUTABLE FILE | Final Rejection | Illumina, Inc. |
| 18193206 | COPY NUMBER VARIANT CALLING FOR LPA KIV-2 REPEAT | Non-Final OA | Illumina, Inc. |
| 16333933 | SOMATIC COPY NUMBER VARIATION DETECTION | Final Rejection | ILLUMINA, INC. |
| 18429893 | METHODS FOR NON-INVASIVE ASSESSMENT OF GENETIC VARIATIONS | Final Rejection | SEQUENOM, INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy35.4% of resolved applications examined by Janna Nicole Schultzhaus were allowed (96 resolved cases), compared with 28.4% across Art Unit 1631 over the last five years.
This examiner's interview lift is +38.2 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Janna Nicole Schultzhaus took 1,733 days on average from filing to allowance.
Janna Nicole Schultzhaus examines applications in Art Unit 1631 in Tech Center 1700 (Chemistry & Materials).
